Table 1.

Trends in ART Uptake by Sex and ART Eligibility Period Among Adults Registered for HIV Care Under the National Program in Pune, India, From January 2005 to December 2017.^a

	Overall (N = 23 957)			Period Ib (n =13 988)			Period II (n = 8488)			Period III (n = 950)			Period IV (n = 531)
	Male	Female	P	Male	Female	P	Male	Female	P	Male	Female	P	Male	Female	P
Number (%)	12 510 (52)	11 447 (48)		7285 (52)	6703 (48)		4441 (52)	4047 (48)		490 (52)	460 (48)		294 (55)	237 (45)
Eligible for ART at registrationc	8148 (65)	6629 (58)	<.001	4225 (58)	3389 (51)	<.001	3192 (72)	2622 (65)	<.001	437 (89)	381 (83)	.005	294 (100)	237 (100)
ART initiatedd	6529 (80)	5261 (79)	.24	3256 (77)	2510 (74)	.002	2709 (85)	2231 (85)	.82	342 (78)	341 (90)	<.001	222 (76)	179 (76)	>.95
Time to ART initiation,e days
<30	3853 (59)	3013 (57)	<.001	1062 (33)	705 (28)	<.001	2294 (85)	1829 (82)	.03	298 (87)	314 (92)	.18	199 (90)	165 (92)	.47
31-90	1512 (23)	1074 (20)		1220 (37)	827 (33)		242 (9)	217 (10)		31 (10)	17 (5)		19 (9)	13 (7)
91-180	410 (6)	305 (6)		345 (11)	249 (10)		56 (2)	51 (2)		5 (1)	4 (1)		4 (1)	1 (1)
>180	754 (12)	869 (17)		629 (19)	729 (29)		117 (4)	134 (6)		8 (2)	6 (2)		-	-

Abbreviations: ART, antiretroviral therapy.

^a All data presented as n (%) unless otherwise indicated.

^b Period I: January 1, 2005, to November 3, 2011 (ART eligible if CD4 <200 cells/μL), period II: November 4, 2011, to June 23, 2016 (ART eligible if CD4 <350 cells/μL), period III: June 24, 2016, to May 4, 2017 (ART eligible if CD4 ≤500 cells), and period IV: May 5, 2017, to December 31, 2017 (ART eligible irrespective of CD4 count).

^c According to CD4 criteria.

^d Of those who were ART eligible.

^e After ART eligibility by CD4 criteria.